Originally posted by hellouser
wtf is going with HISTOGEN phase 2b?
Collapse
X
-
Histogen isn't a publicly traded company, and Ryan is right. Most companies of this nature are like Histogen, they have to raise capital for each round of clinical trials. They usually have rounds of funding that fund them through a certain point, and then if things go well they have to go through another round of funding to continue. This is the reason they are always presenting at conferences and releasing information in order to drum up interest. Then on the other end of the spectrum you have Follica, who are pretty much completely funded which is why you never hear anything from them.
-
Pre-revenue pharmaceutical companies have to raise money from investors in order to have the millions of dollars it takes to take these products through trials. They also have to maintain employees and facilities, which also costs millions a year. Unfortunately, many of these companies have to spend more time trying to raise the required funds than they do on R and D. Some of them end up running out of money or just putting the process on hold while they raise cash. I'm sure Histogen is facing these same challenges. But it's not as if they are sitting around going "lets play golf all day and make men with hair loss keep fretting for a few more years."
Arent you concerned that they wont hit the market?Leave a comment:
-
Pre-revenue pharmaceutical companies have to raise money from investors in order to have the millions of dollars it takes to take these products through trials. They also have to maintain employees and facilities, which also costs millions a year. Unfortunately, many of these companies have to spend more time trying to raise the required funds than they do on R and D. Some of them end up running out of money or just putting the process on hold while they raise cash. I'm sure Histogen is facing these same challenges. But it's not as if they are sitting around going "lets play golf all day and make men with hair loss keep fretting for a few more years."Leave a comment:
-
Pre-revenue pharmaceutical companies have to raise money from investors in order to have the millions of dollars it takes to take these products through trials. They also have to maintain employees and facilities, which also costs millions a year. Unfortunately, many of these companies have to spend more time trying to raise the required funds than they do on R and D. Some of them end up running out of money or just putting the process on hold while they raise cash. I'm sure Histogen is facing these same challenges. But it's not as if they are sitting around going "lets play golf all day and make men with hair loss keep fretting for a few more years."Leave a comment:
-
-
It's neither incompetence nor the FDA holding them up, it's funding. It's takes a LOT of money to proceed with these things. They have to raise capital to move forward.Leave a comment:
-
But hey science guy... What's the deal with that drug hello was talking about?Leave a comment:
-
Leave a comment:
-
They never said or promised they would start phase two B last year. In fact it would have been pretty much impossible for them to do so as they were barely done with phase 1/2a at that time.
You're such a woman, always creating negative gossip from your imagination, rather than facts. You always do this dude.
You should just face the fact that all the fake timelines that were made by wishful thinkers on this forum are just what they are, nothing more than people's absolute best scenario hypothesis based on facts they don't even know.
Well i can wait, but my balding head can't. it just progresses everyday...
and the question is, will i benefit from Histogen in the future, is there any point for waiting them or waiting for any another treatment?!Leave a comment:
-
You're such a woman, always creating negative gossip from your imagination, rather than facts. You always do this dude.
You should just face the fact that all the fake timelines that were made by wishful thinkers on this forum are just what they are, nothing more than people's absolute best scenario hypothesis based on facts they don't even know.Leave a comment:
-
-
Agreed!!!
You know i recently heard about a guy here that wanted to be a woman. He wanted an operation and all, and i was shocked to found out that apparently a sex change is considered a health problem. So he gets a big refund for his medication and operation while a hair transplantation or any other form of hair maintaining products is considered cosmetic What a load of crap!!!Leave a comment:
-
I am NW7 and I would not give more than $10K to get all my hair back. Of course in this NW grade there is no reasonable solution today.
Baldness should stop being considered as a cosmetic issue. It must gain the status of a health problem to be treated for cheap, reimbursed partly by insurance companies. Just look at the havoc it wrecks in the psychology of younger men and the social problems it creates for them in many developed countries (the U.S.A. and Canada being the flagships in this). Again, it is not a cosmetic issue.
You know i recently heard about a guy here that wanted to be a woman. He wanted an operation and all, and i was shocked to found out that apparently a sex change is considered a health problem. So he gets a big refund for his medication and operation while a hair transplantation or any other form of hair maintaining products is considered cosmetic What a load of crap!!!Leave a comment:
-
I think our complaints and demands about the current state of the hair loss world and especially biotechs and researchers is falling on deaf ears... they don't seem to care enough to actually put a product out the door but rather stall, delay, backtrack or fold completely.
More important than an advance would be a group of researchers or a biotech that isn't incompetent... like Aderans.Leave a comment:
Leave a comment: